期刊文献+

红景天注射液联合氯吡格雷治疗不稳定型心绞痛的临床疗效 被引量:7

Therapeutic effects of Hongjingtian injection combined with clopidogrel on unstable angina pectoris
下载PDF
导出
摘要 目的观察红景天注射液联合氯吡格雷治疗不稳定型心绞痛的临床疗效。方法选择住院治疗的81例不稳定型心绞痛患者,随机分为氯吡格雷组、联合治疗组和对照组,每组27例,观察3组患者治疗前和治疗6个月后的临床症状,并对患者的血液流变学指标变化和不稳定型心绞痛的发作频率、持续时间进行监测。结果联合治疗组和氯吡格雷组心绞痛症状改善总有效率,显著高于对照组(P<0.05)。治疗后联合治疗组患者的全血黏度、红细胞压积和纤维蛋白原指标均显著低于对照组和氯吡格雷组(P<0.05),并且不稳定型心绞痛的发作频率和每次发作持续时间均显著低于氯吡格雷组和对照组(P<0.05)。结论红景天注射液联合氯吡格雷在治疗不稳定型心绞痛的临床应用中具有良好的效果,有效控制了患者病情的反复发作和进一步恶化,值得在临床上推广应用。 Objective To observe the therapeutic effects of Hongjingtian injection combined with clopidogrel on unstable angina pectoris( UAP). Methods Eighty-one patients with unstable angina pectoris who were admitted and treated in our hospital from January 2014 to January 2015 were randomly divided into clopidogrel group,combination treatment group and control group,with 27 patients in each group. The changes of clinical symptoms,hemorheology parameters,attack frequency and duration of UAP were observed before treatment and 6 months after treatment in the three groups. Results The total effective rates of improving angina pectoris in combination treatment group and clopidogrel group were significantly higher than those in control group( P 〈0. 05). The whole blood viscosity,hematocrit and fibrinogen in combination treatment group were significantly lower than those in control group and clopidogrel group( P 〈0. 05),moreover,the attack frequency and duration of UAP in combination treatment group were significantly lower than those in control group and clopidogrel group( P 〈0. 05). Conclusion Hongjingtian injection combined with clopidogrel has obvious therapeutic effects on UAP,which can effectively control the recurrent attacks and aggravation of disease,thus which is worth being widely applied in clinical practice.
作者 张兰 路广秀
出处 《河北医药》 CAS 2016年第14期2140-2142,共3页 Hebei Medical Journal
关键词 红景天注射液 氯吡格雷 联合 不稳定型心绞痛 临床疗效 Hongjingtian injection clopidogrel combination unstable angina pectoris clinical curative effects
  • 相关文献

参考文献12

二级参考文献37

  • 1王骏,励建安,金挺剑,陈子庆,顾劲扬,王元会.心肌缺血日负荷对新西兰兔血管内皮生长因子表达的影响[J].中国康复医学杂志,2005,20(3):165-168. 被引量:18
  • 2储戟农,张早华,刘建勋,尚晓泓,林成仁,马晓斌,石体仁,王敏,张德山,赵志会.红景天注射液对动物血小板聚集、体外血栓形成及血液黏度的影响[J].中国实验方剂学杂志,2005,11(5):39-41. 被引量:40
  • 3国际心脏病学会和协会及世界卫生组织命名标准化联合专题组.缺血型心脏病的命名及诊断标准[J].中华心血管病杂志,1981,9(1):75-75.
  • 4陈灏珠,主编.实用内科学[M]第12版.北京:人民卫生出版社,2005.1 231-1 245.
  • 5.中药新药临床研究指导原则[S].[S].中华人民共和国卫生部,1993.57.
  • 6Szinnai G, Morgenthaler N G, Berneis K, et al. Changes in plasma eopeptin, the c-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects [ J ]. J Clin Endocrinol Metab, 2007, 92( 10): 3973-3978.
  • 7Katan M, Morgenthaler N G, Dixit K C, et al. Anterior and posterior pituitary function testing with simultaneous insulin tolerance test and a novel copeptin assay [ J ]. J Clin Endocrinol Metab, 2007, 92 ( 7 ) : 2640- 2643.
  • 8Kelly D, Squire I B, Khan S Q, et al. C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction [ J ]. J Card Fail, 2008, 14(9) : 739 -745.
  • 9Keller T, Tzikas S, Zeller T, et al. Copeptin improves early diagnosis of acute myocardial infarction [ J ]. J Am Coil Cardiol, 2010, 55 (19) : 2096 - 2106.
  • 10Khan S Q, Dhillon O S, O' Brien R J, et al. C-terminal provasopres- sin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study[ J]. Circulation, 2007, 115 (16) : 2103 - 2110.

共引文献62

同被引文献48

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部